What happens when a cyclist and a driver remember the same crash differently? In Charlotte, that question can become important when an insurance company begins reviewing a bicycle injury claim and comparing statements from the people involved with photographs, medical records, witness accounts, and other evidence. Differences in recollection do not automatically prevent recovery, but […]
FDA’s 2020 removal request concerned the ranitidine products then on the market. In November 2025, FDA approved reformulated ranitidine tablets. Those are different regulatory events; an older recall article should not be used by itself to decide whether a current medication is appropriate.
FDA’s 2020 request
In April 2020, the FDA requested the removal of all prescription and over-the-counter ranitidine products from the U.S. market. FDA explained that NDMA levels could increase over time and with storage at higher-than-room temperatures. The notice is not a clinical diagnosis and does not identify what a particular person’s medical records establish.
FDA’s 2025 approval of reformulated tablets
On November 24, 2025, FDA announced approval of reformulated ranitidine tablets after safety testing and manufacturing changes addressing previous NDMA impurity concerns. The announcement includes updated storage and handling instructions and advises people using other medicines to consult their healthcare provider before switching.
The new approval does not identify the condition of a particular older package or establish whether a medication caused an individual illness. Keep the product, formulation, dates and source records distinct when asking a health professional or lawyer about a specific concern.
Use current medical and product information
For a question about a current medication, speak with an appropriate health professional or pharmacist and consult current FDA information. Do not stop, start, or substitute medication based solely on a historical web article.
Keep original information if it is relevant
- Medication name, packaging, lot information, dates, and pharmacy or purchase records
- Medical records and instructions kept in their original form
- FDA notices and communications relevant to the product
- A clear distinction between a product notice and an individual medical or legal conclusion
Questions about a possible North Carolina personal-injury matter depend on the evidence, applicable law, and individual circumstances.
Source
Additional Personal Injury Articles
What to Know About Ongoing Claim Evaluation Processes During a Difficult Recovery
Ongoing claim evaluation often depends on how clearly the events surrounding an injury are documented from the beginning. Written statements, medical records, photographs, work records, and communications with insurers can all influence how an accident and its consequences are understood weeks or months later. For a family in Charlotte dealing with medical appointments, transportation problems, […]
Keeping Records After Claim Closure in Case New Issues Develop
After an insurance claim closes, the paperwork connected to the accident can still matter months or even years later. A driver may feel relieved when repairs are completed, medical bills appear resolved, and the insurer marks the file closed, but later developments can make old records important again. Symptoms may return, a medical provider may […]
How Recovery Time Affects Motorcycle Claims and the Records That Can Support Your Case
A motorcycle crash can disrupt more than a rider’s health. It can affect work, family responsibilities, transportation, and household finances for weeks or months. Medical records created during that period help show how the injuries developed, how consistently the rider followed treatment recommendations, and when daily life began returning to normal. Why the Timeline Matters […]
